Received 0 Karma
Received 0 Karma

[TimAlerts] AXON "Axovant's RVT-101 Phase 2b Completer Analysis Demonstrates Statistically Significant Benefits in Cognition and Function Through 48 Weeks" http://finance.yahoo.com/news/axovants-rvt-101-phase-2b-160000453.html
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma
Received 0 Karma

